Nanomedicine and Nanobiology
A section of Biomedicines (ISSN 2227-9059).
Section Information
This Section of Biomedicines aims to rapidly publish contributions on synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; and interactions of nanomaterials with cells, tissues, and living organisms.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Nanoparticles and Biomaterials: Pioneering Innovations in Biomedical Device Engineering (Deadline: 30 June 2026)
- Nanomaterials for Drug Delivery: Current Status and Future Prospects (Deadline: 30 June 2026)
- Unleashing the Power of Innovative Nanoparticles for Enhanced Radiation Therapy (Deadline: 31 July 2026)
- Advanced Development on Lipid Nanoparticles (Deadline: 31 July 2026)
- Advanced Research in Mitochondrial Medicine and Nanomedicine (Deadline: 31 August 2026)
- Nanotechnology in Pharmaceuticals (Deadline: 31 August 2026)
- Nanostructures in Medicine: State of the Art and Future Challenges (Deadline: 31 August 2026)
- Horizons in Drug Discovery, Development, and Delivery (Deadline: 31 August 2026)
- Next-Generation Nanoparticles: Innovations in Biomedical Applications and Theranostics (Deadline: 30 September 2026)
- Drug Delivery and Nanocarrier (Deadline: 30 September 2026)
- Advanced Nanomaterials for Nanomedicine: From Functional Nanoprobes and Nanomaterials to Theragnostic Applications (Deadline: 30 September 2026)
- Nanoparticles in Biomedical Engineering: From Drug Delivery to Tissue Engineering (Deadline: 30 November 2026)
- Biomaterials and Nanotechnology for Advanced Wound Dressings (Deadline: 30 November 2026)
- Advanced Nanomaterials and Nanotechnology for Precision Biomedicine and Drug Delivery (Deadline: 30 November 2026)
- Emerging Trends and Applications in Nanomedicine and Targeted Therapies (Deadline: 31 December 2026)
